PPI Marketers Target Patients Leaving COX-2s For NSAIDs
This article was originally published in The Tan Sheet
Executive Summary
Proton pump inhibitor marketers are poised to benefit from potential cardiovascular risk warnings for COX-2 inhibitors that could increase the migration of arthritis patients to traditional NSAIDs